News

January 18, 2019January 18, 2019

PH Linked to Bronchopulmonary Dysplasia Resolves Over Time in Many Preemies, Study Reports

News, PH News

Pulmonary hypertension (PH) associated with bronchopulmonary dysplasia (BPD) resolves over time in nearly two-thirds of premature babies, a study shows. However, the findings also revealed that being male, steroid ... Read more

January 17, 2019January 17, 2019

Dutch Hospital Uses Non-invasive Tool to Diagnose PH in Sarcoidosis Patients Early

News

Doctors in the Netherlands are using the VMS Heart Analysis System, developed by Ventripoint Diagnostics, for early diagnosis of pulmonary hypertension (PH) in sarcoidosis patients. Approximately 500 patients with ... Read more

January 16, 2019January 16, 2019

Tracleer May Be More Cost-effective Than Some Other PAH Therapies, Review Study Reports

News, PAH News

Treatment of pulmonary arterial hypertension (PAH) with Tracleer (bosentan) may be more cost-effective than epoprostenol medications or palliative care, but less than Revatio (sildenafil) and other endothelin receptor blockers, ... Read more

January 14, 2019January 17, 2019

β-thalassemia Patients at Risk for PAH Show Improvements on Tracleer, Case Report Says

News, PAH News

Tracleer (bosentan) treatment improves mean pulmonary arterial pressure (mPAP) in β-thalassemia patients with potential pulmonary arterial hypertension (PAH), according to a case report of three patients. The report, “The ... Read more

January 11, 2019January 14, 2019

Long-term Adempas Treatment May Reverse Right Heart Deficits in Patients with PAH, CTEPH, Study Finds

CTEPH News, News, PAH News

Long-term treatment with Adempas (riociguat) can reduce right heart size and improve the heart’s pumping function in patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH), ... Read more

January 10, 2019January 10, 2019

INOpulse Device Improves Physical Activity in PH-ILD Patients, Phase 2b Trial Shows

News

Treatment with INOpulse for eight weeks is safe and provides clinically meaningful improvements in physical activity in patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD), according to ... Read more

January 9, 2019January 9, 2019

Team PHenomenal Hope Accepting Applications for Research Grants

News, PH News

With the goal of enhancing the lives of pulmonary hypertension (PH) patients, including through better medical care, the nonprofit Team PHenomenal Hope (Team PH) is accepting applications for early-career ... Read more

January 7, 2019January 7, 2019

Repeated Measurements of Biomarkers May Improve Prognostic Accuracy in PAH-CHD Patients, Study Finds

News, PAH News

Repeated measurements of different biomarkers over time offer a better risk prediction than single measurements for pulmonary arterial hypertension (PAH) associated with congenital heart disease, a study reports. The ... Read more

January 4, 2019January 4, 2019

Chinese PH Patients Form Beijing-based Advocacy Group

News, PH News

Pulmonary hypertension (PH) patients in China, the world’s most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary Hypertension Hope Center, whose website is available only in ... Read more

January 3, 2019January 11, 2019

Obstructive Sleep Apnea Affects Cardiac Function of CTEPH Patients

CTEPH News, News

Worse measures of blood flow, arterial oxygenation, and cardiac function may underlie the poor clinical condition of chronic thromboembolic pulmonary hypertension (CTEPH) patients who also have obstructive sleep apnea ... Read more

Pin It on Pinterest